IgE modification of the specific antidermatophagoides during the first year of specific immunotherapy (SIT).
Six subjects (4 female, 2 male), aged from 16 to 25 years, presented with allergic rhinitis to Dermatophagoides mites and received SIT by the sub-cutaneous route with delayed-release alpha fraction Bayropharm at the standard doses. Diagnosis was based on clinical history, skin tests and measurement of specific IgE at 0, 3, 9, and 12 months, by the fluoro-enzymatic technique (FAST). For comparison, in a reference group (n = 20) the IgE varied between 0.32 and 0.11 IU/ml for D1 and 0.31 to 0.09 IU/ml for D2. The eight patients had specific IgE titres of D1 = 0.96, D2 = 0.99. For these authors, the FAST technique used for the measurement of specific IgE, although less sensitive than the RIA technique of RAST, gives a good evaluation of SIT.
Vanacore
R
R
Clinica Medica I, Universita di Pisa, Italia.
Ferrara
M P
MP
Berni
R
R
Luchetti
A
A
Gianfaldoni
M L
ML
Sbrana
S
S
Ambrogi
F
F
D000293:Adolescent; D000328:Adult; D000485:Allergens / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use*; D000818:Animals; D039741:Antigens, Dermatophagoides; D003692:Delayed-Action Preparations; D003888:Desensitization, Immunologic; D004391:Dust; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D007124:Immunoenzyme Techniques; D007073:Immunoglobulin E / Q000097:blood*; D007279:Injections, Subcutaneous; D008297:Male; D008925:Mites / Q000276:immunology*; D012221:Rhinitis, Allergic, Perennial / Q000276:immunology / Q000628:therapy*
D000485:Allergens; D039741:Antigens, Dermatophagoides; D003692:Delayed-Action Preparations; D004391:Dust; D007073:Immunoglobulin E